Nuvo Pharmaceuticals (MRV) Stock Price, News & Analysis

Company Overview

To deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for over 25 years, we move, store, process and secure the world's data with semiconductor solutions designed for our customers' current needs and future ambitions. Through a process of deep collaboration and transparency, we're ultimately changing the way tomorrow's enterprise, cloud, automotive, and carrier architectures transform-for the better.

Key Stats

• Today's Range: C$27.76 to C$29.59
• 50-Day Range: N/A
• 52-Week Range: C$26.00 to C$29.59
• Volume: 12,235 shs
• Average Volume: 9,146 shs
• Market Capitalization: C$25.31 billion
• P/E Ratio: 9.43
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:MRV
• CIK: N/A
• Web: www.miravohealthcare.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C$3.07
• Trailing P/E Ratio: 9.43
• Forward P/E Ratio: 420.38
• P/E Growth: N/A
• Net Income: C$15.17 million
• Net Margins: 20.95%
• Pretax Margin: N/A
• Return on Equity: 1,180.47%
• Return on Assets: 5.85%

Debt

• Debt-to-Equity Ratio: 1,165.85
• Current Ratio: 2.11
• Quick Ratio: 1.68

Sales & Book Value

• Annual Sales: C$8.19 billion
• Price / Sales: 3.09
• Cash Flow: C$128.11 per share
• Price / Cash Flow: 0.23
• Book Value: C$0.75 per share
• Price / Book: 38.59

Miscellaneous

• Outstanding Shares: 874,458,000
• Free Float: N/A
• Market Cap: C$25.31 billion
• Optionable: Not Optionable
• Beta: 0.92